Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation Research

• Publication date

  2001-09-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HH1901.098735PMID 11577031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

  2001cited by this paper
• Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

  2001cited by this paper
• Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β

  2001cited by this paper
• Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

  2000cited by this paper
• Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.

  2000cited by this paper
• IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma.

  2000cited by this paper
• Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death.

  2000cited by this paper
• IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

  2000cited by this paper
• Interleukin-18, a proinflammatory cytokine.

  2000cited by this paper
• Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity.

  1999cited by this paper
• Protective role of interleukin-10 in atherosclerosis.

  1999cited by this paper
• Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death.

  1999cited by this paper
• Interleukin-18 Regulation of Interferon γ Production and Cell Proliferation as Shown in Interleukin-1β–Converting Enzyme (Caspase-1)-Deficient Mice

  1998cited by this paper
• IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.

  1997cited by this paper
• The unstable atheroma.

  1997cited by this paper
• The composition of coronary-artery plaques.

  1997cited by this paper
• IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

  1997cited by this paper
• Effect of Chronic Dihydropyridine (Isradipine) on the Large Arterial Walls of Spontaneously Hypertensive Rats

  1994cited by this paper
• Endotoxin-induced serum factor that stimulates gamma interferon production

  1989cited by this paper

• Interleukin-18 Inhibition Aggravates Atherosclerosis in Jak2V617F Clonal Hematopoiesis.

  2026cites this paper
• Cellular aspects of immunity involved in the development of atherosclerosis

  2025cites this paper
• IV IL-1 receptor antagonist reduces pain sensitivity and enhances brain endorphin release during a standardized, experimental, acute pain challenge: A BESH clinical trial.

  2025cites this paper
• Genomic Locus Tagged by Lung Function GWAS SNV rs12477314 (2q37.3) Acts as a Regulatory Region for a Systemic Inflammatory Phenotype

  2025cites this paper
• Effect of Tumor Necrosis Factor Alpha Inhibitor and Interleukin-6 Inhibitor Therapy on Endothelial Dysfunction in Patients with Rheumatoid Arthritis

  2025cites this paper
• Unleashing the potential of exercise: conquering cardiovascular disease by targeting inflammasome activation

  2025cites this paper
• The role of absent in melanoma 2 (AIM2) in cardiovascular diseases

  2025cites this paper
• Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling

  2025cites this paper
• IL-1 family cytokines in inflammation and immunity

  2025cites this paper
• Modulation of IL-1, IL-6 and IL-18 cytokine signaling in animal models of atherosclerosis: a systematic review evaluating animal sex in preclinical research.

  2025cites this paper
• IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling.

  2025cites this paper
• Association of carotid atheroma plaque with IL-18 levels and with polymorphisms in the IL-18 receptor gene in a Mediterranean population.

  2024cites this paper
• The Serum NLRP1 Level and Coronary Artery Calcification: From Association to Development of a Risk-Prediction Nomogram

  2024cites this paper
• Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner

  2024cites this paper
• Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen

  2024cites this paper
• EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells

  2024cites this paper
• A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets

  2024cites this paper
• Linking MASLD to ACVD through Kupffer cells

  2024cites this paper
• The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease

  2024cites this paper
• COVID-19 in the Initiation and Progression of Atherosclerosis

  2024cites this paper
• Canonical and non-canonical functions of NLRP3

  2023cites this paper
• Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management

  2023cites this paper
• Validating human and mouse tissues commonly used in atherosclerosis research with coronary and aortic reference tissue: similarities but profound differences in disease initiation and plaque stability

  2023cites this paper
• Vitamin D Status Modestly Regulates NOD-Like Receptor Family with a Pyrin Domain 3 Inflammasome and Interleukin Profiles among Arab Adults

  2023cites this paper
• Plausible Role of NLRP3 Inflammasome and Associated Cytokines in Pathogenesis of Rheumatic Heart Disease.

  2023cites this paper
• NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome

  2023cites this paper
• Artificial Intelligence in Symptomatic Carotid Plaque Detection: A Narrative Review

  2023cites this paper
• Young, hot and sweet: The complex relationship of inflammation, type 1 diabetes, and vascular health.

  2023cites this paper
• Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship

  2023cites this paper
• Ferroptosis Involved in Cardiovascular Diseases: Mechanism Exploration of Ferroptosis' Role in Common Pathological Changes.

  2023cites this paper
• NOD-like Receptors—Emerging Links to Obesity and Associated Morbidities

  2023cites this paper
• Bone marrow mesenchymal stem cellsderived exosomes stabilize atherosclerosis through inhibiting pyroptosis

  2023cites this paper
• Interleukin-18 and IL-18BP in inflammatory dermatological diseases

  2023cites this paper
• Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation

  2022cites this paper
• The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies

  2022cites this paper
• Cytokines associated with immune response in atherosclerosis.

  2022cites this paper
• Anti-inflammatory drug combination therapy for atherosclerosis: colchicine and fenofibrate.

  2022cites this paper
• Enhanced platelet NLRP3 inflammasome expression in patients with acute coronary syndrome and stable coronary artery disease: A prospective observational study

  2022cites this paper
• Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study

  2022cites this paper
• Interleukin-18 and cardiovascular diseases: a literature review

  2022cites this paper
• Ferroptosis: A Potential Target in Cardiovascular Disease

  2022cites this paper
• Interleukin-18 and cardiovascular diseases: a literature review

  2022cites this paper
• Human Plasma Transcriptome Implicates Dysregulated S100A12 Expression: A Strong, Early-Stage Prognostic Factor in ST-Segment Elevated Myocardial Infarction: Bioinformatics Analysis and Experimental Verification

  2022cites this paper
• Emerging Roles of Inflammasomes in Cardiovascular Diseases

  2022cites this paper
• When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors

  2022cites this paper
• Global research trends in atherosclerosis: A bibliometric and visualized study

  2022cites this paper
• IL18 signaling causes islet β cell development and insulin secretion via different receptors on acinar and β cells.

  2022cites this paper
• Adipokines, adiposity, and atherosclerosis

  2022cites this paper
• Kupffer cells dictate hepatic responses to the atherogenic dyslipidemic insult

  2022cites this paper
• The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases

  2022cites this paper
• NLRP3 inflammasome as a key driver of vascular disease.

  2021cites this paper
• Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis

  2021cites this paper
• Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis

  2021cites this paper
• The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.

  2021cites this paper
• Gastrodin induces lysosomal biogenesis and autophagy to prevent the formation of foam cells via AMPK‐FoxO1‐TFEB signalling axis

  2021cites this paper
• Biomarkers in unstable carotid plaque: Physiopathology and Prediction.

  2021cites this paper
• Non-coding RNAs Related to Atherosclerosis

  2021cites this paper
• Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?

  2021cites this paper
• Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?

  2021cites this paper
• Identifying young adults at high risk of cardiometabolic disease using cluster analysis and the Framingham 30-yr risk score.

  2021cites this paper
• Cardiometabolic risks and atherosclerotic disease in ApoE knockout mice: Effect of spinal cord injury and Salsalate anti-inflammatory pharmacotherapy

  2021cites this paper
• Anti-atherosclerotic activity of Betulinic acid loaded polyvinyl alcohol/methylacrylate grafted Lignin polymer in high fat diet induced atherosclerosis model rats

  2020cites this paper
• Influence of Natural Killer Cells and Natural Killer T Cells on Periodontal Disease: A Systematic Review of the Current Literature

  2020cites this paper
• Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.

  2020cites this paper
• The secretome of liver X receptor agonist‐treated early outgrowth cells decreases atherosclerosis in Ldlr−/− mice

  2020cites this paper
• Focus on the Role of NLRP3 Inflammasome in Diseases

  2020cites this paper
• Inflammatory Cytokines During Cardiac Rehabilitation After Heart Surgery and Their Association to Postoperative Atrial Fibrillation

  2020cites this paper
• Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction

  2020cites this paper
• ABC Transporters, Cholesterol Efflux, and Implications for Cardiovascular Diseases.

  2020cites this paper
• Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

  2020cites this paper
• The role of interleukin-18 in the development and progression of atherosclerosis.

  2020cites this paper
• The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury

  2020cites this paper
• Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead

  2020influential citation
• Physiopathologie de l’athérosclérose

  2020cites this paper
• Inflammasome Expression and Activation in Human Atherosclerosis

  2019cites this paper
• Angeborene Immunität und Adipositas – Die Rolle der Nod-like-Rezeptoren (NLR)

  2019cites this paper
• Chapter 2 Cytokines and Immune Responses in Murine Atherosclerosis

  2019cites this paper
• Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

  2019cites this paper
• Epigenetic Age Acceleration in Adolescence Associates With BMI, Inflammation, and Risk Score for Middle Age Cardiovascular Disease.

  2019cites this paper
• Immunobiology of Atherosclerosis: A Complex Net of Interactions

  2019cites this paper
• IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential.

  2019cites this paper
• Macrophages and T cells in atherosclerosis: a translational perspective.

  2019cites this paper
• Analysis of interleukin-17 and interleukin-18 levels in animal models of atherosclerosis

  2019cites this paper
• Inflammation as a Therapeutic Target in Atherosclerosis

  2019influential citation
• A multiphase model of growth factor-regulated atherosclerotic cap formation

  2019influential citation
• Deletion of interleukin-18 attenuates abdominal aortic aneurysm formation.

  2019cites this paper
• NLRP3: A Novel Mediator in Cardiovascular Disease

  2018cites this paper
• Mitochondria-associated membranes (MAMs) and inflammation

  2018cites this paper
• The Role of Interleukin-1 Beta in Mediating LPS-Induced Reverse Transendothelial Migration of Intimal Dendritic Cells

  2018cites this paper
• Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives

  2018cites this paper
• Serum interleukin-18 and extent of coronary artery disease in unstable angina

  2018cites this paper
• Innate and adaptive immunity in atherosclerosis.

  2018cites this paper
• The effect of salusin-β on expression of pro- and anti-inflammatory cytokines in human umbilical vein endothelial cells (HUVECs)

  2018cites this paper
• Genetic association of Tumour necrosis factor alpha, Interleukin-18 and Interleukin 1 beta with the risk of coronary artery disease: A case-control study outcome from Kashmir

  2018cites this paper
• Ccl17-dependent release of Ccl3 restrains regulatory T cells thereby aggravating atherosclerosis

  2018cites this paper
• Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells

  2018cites this paper
• Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis

  2018cites this paper
• A two-phase model of early fibrous cap formation in atherosclerosis.

  2018cites this paper
• Terminalia arjuna prevents Interleukin-18-induced atherosclerosis via modulation of NF-κB/PPAR-γ-mediated pathway in Apo E−/− mice

  2018cites this paper
• NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

  2018cites this paper